Organogenesis Holdings Inc.ORGO

Market cap

$376.32M

P/E ratio

	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Revenues	-	-	193	261	338	468	451
Cost of Revenue	-	-	69	76	87	114	105
Gross profit	-	-	125	185	251	354	346
Selling, general and administrative	-	-	162	200	203	250	284
Research and development	-	-	11	15	20	31	40
Total operating expenses	208,698	5	176	214	224	281	324
Income from operations	-	-4,591,834	-52	-29	27	73	22
Interest expense	-	-	11	9	11	7	2
Gain on settlement of deferred acquisition consideration	-	-	-	-	2	-	-
Change in fair value of warrant liability	-	-	0	-	-	-	-
Loss on the extinguishment of debt	-	-	-2	-2	-	-2	-
Other income (loss), net	-	-	0	0	0	-0	-0
Total other expense, net	-	-	-13	-11	-9	-9	-2
Net income before income taxes	-	-	-65	-40	18	64	20
Income tax (expense) benefit	-	-	0	0	1	-31	5
Net income	-208,698	-2,093,913	-65	-40	18	95	16
Net income (loss) attributed to common shareholders	-	-	-	-41	18	95	-
Basic	-	-	-	-	0.17	0.74	0.12
Diluted	-	-	-	-	0.16	0.71	0.12